Volume 95 Issue 34 | p. 15 | Concentrates
Issue Date: August 28, 2017

J&J deepens TB drug commitment

Department: Business
Keywords: Infectious disease, tuberculosis, TB, J&J

Johnson & Johnson has teamed with India’s Institute of Microbial Technology (IMTECH) to develop new treatments for tuberculosis. The goal is safer, more effective, all-oral treatments for multi-drug-resistant TB, as well as TB drugs with novel mechanisms for all people with TB. Scientists from J&J and IMTECH will work together to tackle TB, which in 2015 killed nearly 500,000 people in India. In late 2012, J&J received approval for Sirturo, the first new TB treatment in 40 years.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment